Last week Molecular Mining completed its second round of financing, securing over $8 million. The round was led by CDP Sofinov, a subsidiary of the Caisse de Depot et Placement du Quebec.
Other investors included the Business Development Bank of Canada; S.R. One, a subsidiary of GlaxoSmithKline; Cardinal Partners; and CMDF Queen’s Scientific Breakthrough Fund.
S.R. One and Cardinal Partners also participated in Molecular Mining’s initial $2 million round of financing in March 1999.